CLINICAL_TRIALS
trial_result
· 2017-10-26
Clinical Trial Update: Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients [Phase 2, Phase 3]
Summary
This document provides an update on a Phase 2/3 clinical trial evaluating simvastatin as a steroid-sparing treatment for uveitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University College, London | Conditions: Uveitis | Phase 2, Phase 3 | Status: UNKNOWN